Emanuela Leuci Selected Research

Polytetrafluoroethylene (Teflon)

11/2022	Association between case management and longitudinal decrease in negative symptoms in patients with first episode psychosis: A 2-year follow-up.
5/2022	Individual psychotherapy can reduce suicidal ideation in first episode psychosis: Further findings from the 2-year follow-up of the 'Parma Early Psychosis' programme.
1/2022	Personal health budget in patients with first episode psychosis: A new rehabilitation model based on a community care system in Italy.
1/2022	Examining disorganization in patients with first episode psychosis: Findings from a 1-year follow-up of the 'Parma early psychosis' program.
1/2021	The 'Parma-Early Psychosis' programme: Characterization of help-seekers with first episode psychosis.
12/2020	Negative symptom configuration within and outside schizophrenia spectrum disorders: results from the "Parma Early Psychosis" program.
1/2020	The "Parma-Early Psychosis" program: General description and process analysis after 5 years of clinical activity.
1/2020	Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis.
1/2020	Suicidal Ideation in Patients Experiencing a First-episode Psychosis: Findings From the 2-Year Follow-up of the "Parma Early Psychosis" Program.
12/2019	Dimensional structure of first episode psychosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emanuela Leuci Research Topics

Disease

14	Psychotic Disorders (Schizoaffective Disorder) 11/2022 - 05/2012
6	Schizophrenia (Dementia Praecox) 01/2022 - 01/2015
1	Mental Disorders (Mental Disorder) 01/2021
1	Genetic Risk Score 01/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2020

Drug/Important Bio-Agent (IBA)

14	Polytetrafluoroethylene (Teflon)FDA Link 11/2022 - 05/2012
3	ElementsIBA 01/2017 - 05/2012
2	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2022 - 12/2020
1	SolutionsIBA 01/2021
1	GhrelinIBA 01/2020
1	Biological ProductsIBA 01/2020
1	LigandsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	ChemokinesIBA 01/2020

Therapy/Procedure

2	ICE protocol 1 11/2022 - 05/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Self-Testing 01/2015